Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Prudent

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Review of Molecular Diagnostics|March 4, 2006
Using expanded genetic alphabets to simplify high-throughput genetic testingJames R Prudent
Nucleic Acids Research|August 22, 2003
Enzymatic repair of an expanded genetic information systemMichael J Moser, James R Prudent
The Journal of Molecular Diagnostics : JMD|January 27, 2006
Multiplexed detection of anthrax-related toxin genesMichael J Moser, Deanna R Christensen, David Norwood, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 21, 2006
A continuous assay for DNA cleavage using molecular break lightsJohn B Biggins, James R Prudent, David J Marshall, et al.
Nucleic Acids Research|March 31, 2004
A third base pair for the polymerase chain reaction: inserting isoC and isoGScott C Johnson, Christopher B Sherrill, David J Marshall, et al.
Journal of Clinical Microbiology|September 29, 2006
MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samplesEvguenia S Svarovskaia, Michael J Moser, Andrew S Bae, et al.
Oral Oncology|August 8, 2013
A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinomaLarissa Sweeny, Yolanda E Hartman, Kurt R Zinn, et al.
Journal of the American Chemical Society|April 9, 2004
Nucleic acid analysis using an expanded genetic alphabet to quench fluorescenceChristopher B Sherrill, David J Marshall, Michael J Moser, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1Michael J Moser, Meta Ruckstuhl, Christine A Larsen, et al.
Oncotarget|February 5, 2017
Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypesSamuel Jang, Xiao-Min Yu, Celina Montemayor-Garcia, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|March 4, 2006
Using expanded genetic alphabets to simplify high-throughput genetic testingJames R Prudent
Nucleic Acids Research|August 22, 2003
Enzymatic repair of an expanded genetic information systemMichael J Moser, James R Prudent
The Journal of Molecular Diagnostics : JMD|January 27, 2006
Multiplexed detection of anthrax-related toxin genesMichael J Moser, Deanna R Christensen, David Norwood, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 21, 2006
A continuous assay for DNA cleavage using molecular break lightsJohn B Biggins, James R Prudent, David J Marshall, et al.
Nucleic Acids Research|March 31, 2004
A third base pair for the polymerase chain reaction: inserting isoC and isoGScott C Johnson, Christopher B Sherrill, David J Marshall, et al.
Journal of Clinical Microbiology|September 29, 2006
MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samplesEvguenia S Svarovskaia, Michael J Moser, Andrew S Bae, et al.
Oral Oncology|August 8, 2013
A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinomaLarissa Sweeny, Yolanda E Hartman, Kurt R Zinn, et al.
Journal of the American Chemical Society|April 9, 2004
Nucleic acid analysis using an expanded genetic alphabet to quench fluorescenceChristopher B Sherrill, David J Marshall, Michael J Moser, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1Michael J Moser, Meta Ruckstuhl, Christine A Larsen, et al.
Oncotarget|February 5, 2017
Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypesSamuel Jang, Xiao-Min Yu, Celina Montemayor-Garcia, et al.
Pageof 2